StockStory backs TD SYNNEX while warning on Kyndryl and RUM
The publisher cites TD SYNNEX's growth and scale, while pointing to declining revenue at Kyndryl and cash risks at RUM.
Makkler Newsroom · Oct 9, 12:19 PM · 1 min read
Market closed· · USD · Data may be delayed
Avg. target $21.33 (+269.7%)
Prices may be delayed and are for informational purposes only - not investment advice.
The publisher cites TD SYNNEX's growth and scale, while pointing to declining revenue at Kyndryl and cash risks at RUM.
Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.